DNA Nanoarrays Scalable Fabrication via PCR Amplification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing DNA nanoarrays face challenges in scaling beyond 10K diverse single molecules due to high synthesis costs and stochastic self-assembly limitations, making it difficult to achieve low-cost, independent nanoscale manipulation and precise placement of uniquely addressable DNA nanostructures.
Innovation Solution
A DNA nanoarray fabrication method involving a milliscale chip substrate with immobilized oligonucleotide sequences and a method of producing DNA nanoarrays using streptavidin-coated substrates and biotin-tagged oligonucleotides, enabling the creation of a DNA Canvas with millions of uniquely addressable nanopixels through enzymatic reactions and next-generation sequencing, allowing for precise mapping of barcodes to spatial locations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If de novo DNA synthesis is used to create unique sequences, then sequence uniqueness is achieved, but synthesis cost increases significantly
Solution Approach 1:
The patent uses PCR amplification to copy a small number of synthesized DNA templates (containing unique barcodes) to generate millions of identical copies for each spot. This eliminates the need to synthesize unique sequences for every individual DNA molecule, dramatically reducing synthesis costs while maintaining sequence uniqueness at the template level
Solution Approach 2:
The DNA sequence is divided into two functional parts: a unique barcode region (synthesized once per spot) and a repetitive amplicon region (amplified by PCR). This segmentation allows the expensive unique sequencing step to be performed only on templates, while the cheap amplification step generates the required quantity
2Adaptability or versatility
If DNA nanoarrays with millions of unique sequences are produced, then addressability increases, but synthesis complexity increases
Solution Approach 1:
The synthesis process is segmented into two distinct phases: (1) template synthesis with unique barcodes using phosphoramidite chemistry, and (2) exponential amplification using PCR. This segmentation transforms a single complex high-precision process into a two-step process where the first step requires high precision but low throughput, and the second step requires low precision but high throughput
Solution Approach 2:
The unique barcode sequences are synthesized in advance as templates before the amplification step. This preliminary action ensures that sequence uniqueness is established before the complex amplification process begins, simplifying the overall workflow by separating the uniqueness-generation step from the quantity-generation step
3Ease of manufacture
If self-assembly methods are used for DNA nanoarray fabrication, then manufacturing simplicity is maintained, but placement precision decreases
Solution Approach 1:
DNA molecules are pre-functionalized with specific linkers (biotin, digoxigenin, or fluorophores) at defined positions before assembly. This preliminary functionalization ensures that when self-assembly occurs, the functional elements are already in their correct orientations and positions, achieving nanoscale precision through molecular design rather than post-assembly manipulation
Solution Approach 2:
The patent uses intermediary molecules (linkers such as biotin, digoxigenin, or fluorophore-containing spacers) that mediate between the DNA sequence and the final functional structure. These intermediaries provide controlled attachment points that maintain precise spatial relationships during self-assembly, enabling both simplicity and precision
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of scalable, low-cost, uniquely addressable DNA nanoarrays with nanoscale precision, overcoming the limitations of existing methods by reducing synthesis costs and improving the precision and scalability of DNA nanoarray fabrication.
Implementation Method 1
a binder bound to the milliscale chip substrate as a microscale spot having a uniform surface; and immobilized oligonucleotide sequences, each having a linker linked to the binder
Implementation Method 2
A DNA nanoarray fabrication method involving a milliscale chip substrate with immobilized oligonucleotide sequences and a method of producing DNA nanoarrays using streptavidin-coated substrates and biotin-tagged oligonucleotides
Data Source
AI summary
A DNA nanoarray includes a milliscale chip substrate; a microscale binder spot having a uniform surface bound to the substrate; and immobilized oligonucleotide sequences, each linked to the binder. The immobilized oligonucleotide sequences form a monolayer, each having a length that guarantees within a statistical certainty that the immobilized oligonucleotide sequences are each unique. A method of producing the DNA nanoarray includes providing a streptavidin-coated substrate; patterning the substrate by photolithography; and immobilizing biotin-tagged oligonucleotides on the patterned surface. The oligonucleotides each have a unique string of bases. The patterned surface has an array of microscale spots with active streptavidin binding sites. Immobilization includes applying a solution containing the oligonucleotides to the microscale spots; applying a buffer over the patterned surface; and washing the patterned surface in buffered saline solution. Bits and/or spatial patterns may be stored the DNA nanoarray, then read and/or visualized.